<DOC>
	<DOC>NCT02700633</DOC>
	<brief_summary>Pacemaker requirement in the immediate post procedure phase following TAVI is approximately 20% depending on device type and patient characteristics. There is a signal from recent studies suggesting increased risk of sudden cardiac / unexplained death in the first 30-60 days. This study aims to address whether there is a mortality advantage to having a pacemaker in the short term</brief_summary>
	<brief_title>Does Permanent Pacemaker Status Confer Mortality Benefit in the Short Term Post TAVI</brief_title>
	<detailed_description />
	<criteria>All patients post TAVI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>